Why the study?
Does AT2R overexpression reduce neointimal hyperplasia in a rat carotid arterial balloon injury model?
Does AT2R overexpression reduce neointimal hyperplasia in a rat carotid arterial balloon injury model?
Local overexpression of AT2R significantly inhibits the development of neointimal hyperplasia after balloon injury by suppressing VSMC proliferation via down-regulation of ERK1/2 and BTEB2 pathways.
Answers are grounded in this paper and cite their sources.
AT2R gene delivery limits neointimal formation in rat balloon injury; leaves open translation to human restenosis prevention.
Angiotensin II (ANG II) type 2 receptor (AT2R) has been recognized to suppress the proliferation of vascular smooth muscle cells (VSMCs). The aim of the present study was to determine whether AT2R overexpression inhibits neointimal hyperplasia in a rat carotid arterial balloon injury model and to examine the underlying mechanisms of its activity. Balloon-injured rats receiving Ad-AT2R showed significant diminutions in neointimal area and intima/media ratio compared to non-treated rats or rats receiving adenovirus containing green fluorescent protein (Ad-GFP). In addition, extracellular regulated kinase 1/2 (ERK1/2) and basic transcription element-binding protein 2 (BTEB2) were significantly down-regulated in the arteries and VSMCs of Ad-AT2R-treated rats and compared to Ad-GFP-treated rats. However, Ad-AT2R transfection failed to affect the expression of ANG II type 1 receptor (AT1R) in carotid arteries and cultured VSMCs. The present study provides direct evidence that AT2R plays a beneficial role in balloon injury-induced neointimal hyperplasia, which is mainly attributed to the inhibition of VSMC proliferation and involves the down-regulation of the ERK1/2 and BTEB2 pathways, but is independent of the expression of AT1R.
No takes yet. Share an insight, caveat, or question.
Li (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: